Fisher JL - Search Results

1

Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories.

Pilarzyk K, Porcher L, Capell WR, Burbano SD, Davis J, Fisher JL, Gorny N, Petrolle S, Kelly MP. Pilarzyk K, et al. Among authors: fisher jl. Aging Cell. 2022 Oct;21(10):e13687. doi: 10.1111/acel.13687. Epub 2022 Sep 8. Aging Cell. 2022. PMID: 36073342 Free PMC article.

2

PDE11A negatively regulates lithium responsivity.

Pathak G, Agostino MJ, Bishara K, Capell WR, Fisher JL, Hegde S, Ibrahim BA, Pilarzyk K, Sabin C, Tuczkewycz T, Wilson S, Kelly MP. Pathak G, et al. Among authors: fisher jl. Mol Psychiatry. 2017 Dec;22(12):1714-1724. doi: 10.1038/mp.2016.155. Epub 2016 Sep 20. Mol Psychiatry. 2017. PMID: 27646265 Free PMC article.

3

Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles.

Prevot TD, Li G, Vidojevic A, Misquitta KA, Fee C, Santrac A, Knutson DE, Stephen MR, Kodali R, Zahn NM, Arnold LA, Scholze P, Fisher JL, Marković BD, Banasr M, Cook JM, Savic M, Sibille E. Prevot TD, et al. Among authors: fisher jl. Mol Neuropsychiatry. 2019 Apr;5(2):84-97. doi: 10.1159/000496086. Epub 2019 Jan 23. Mol Neuropsychiatry. 2019. PMID: 31192221 Free PMC article.

4

Fluoxetine increases GABA(A) receptor activity through a novel modulatory site.

Robinson RT, Drafts BC, Fisher JL. Robinson RT, et al. Among authors: fisher jl. J Pharmacol Exp Ther. 2003 Mar;304(3):978-84. doi: 10.1124/jpet.102.044834. J Pharmacol Exp Ther. 2003. PMID: 12604672

5

Polytherapy with stiripentol: consider more than just metabolic interactions.

Mott DD, Grosenbaugh DK, Fisher JL. Mott DD, et al. Among authors: fisher jl. Epilepsy Behav. 2013 Dec;29(3):585. doi: 10.1016/j.yebeh.2013.09.008. Epub 2013 Oct 2. Epilepsy Behav. 2013. PMID: 24094845 No abstract available.

6

The α6 GABA_A Receptor Positive Allosteric Modulator DK-I-56-1 Reduces Tic-Related Behaviors in Mouse Models of Tourette Syndrome.

Cadeddu R, Knutson DE, Mosher LJ, Loizou S, Odeh K, Fisher JL, Cook JM, Bortolato M. Cadeddu R, et al. Among authors: fisher jl. Biomolecules. 2021 Jan 28;11(2):175. doi: 10.3390/biom11020175. Biomolecules. 2021. PMID: 33525455 Free PMC article.

7

RNA editing of the GABA(A) receptor alpha3 subunit alters the functional properties of recombinant receptors.

Nimmich ML, Heidelberg LS, Fisher JL. Nimmich ML, et al. Among authors: fisher jl. Neurosci Res. 2009 Apr;63(4):288-93. doi: 10.1016/j.neures.2009.01.003. Neurosci Res. 2009. PMID: 19367790 Free PMC article.

8

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA_A Receptors in the Lung.

Forkuo GS, Nieman AN, Kodali R, Zahn NM, Li G, Rashid Roni MS, Stephen MR, Harris TW, Jahan R, Guthrie ML, Yu OB, Fisher JL, Yocum GT, Emala CW, Steeber DA, Stafford DC, Cook JM, Arnold LA. Forkuo GS, et al. Among authors: fisher jl. Mol Pharm. 2018 May 7;15(5):1766-1777. doi: 10.1021/acs.molpharmaceut.7b01013. Epub 2018 Apr 2. Mol Pharm. 2018. PMID: 29578347 Free PMC article.

9

The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.

Fisher JL. Fisher JL. Neuropharmacology. 2014 Oct;85:9-17. doi: 10.1016/j.neuropharm.2014.05.003. Epub 2014 May 20. Neuropharmacology. 2014. PMID: 24859608 Free PMC article.

10

The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.

Fisher JL. Fisher JL. Neuropharmacology. 2015 Dec;99:471-80. doi: 10.1016/j.neuropharm.2015.08.018. Epub 2015 Aug 13. Neuropharmacology. 2015. PMID: 26277340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page